● Recruiting

Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery

Condition: Retroperitoneal Sarcoma · Sponsor: Brigham and Women's Hospital

PhasePhase 1

Planned participants6

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To determine the safety of moderately hypofractionated radiation in the treatment of primary and locally recurrent RPS, based on the evaluation of acute radiation-related toxicity profile of each participant (30-day radiation toxicity)

This description comes directly from the study's public registry record.

Talk to the study team

Miranda Lam · 617-732-7948 · miranda_lam@dfci.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Brigham and Women's Hospital / Dana Farber Cancer Institute

Boston, Massachusetts, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06812052